One promise, in writing: your price never goes up. Not when your dose doubles. Not ever, per the company’s own pledge. This Sprout Health review weighs that promise against the rest of the record — and the rest of the record is rough.
Start with the numbers. BBB rating: F, with 63 complaints and 32 never answered. Trustpilot: roughly 2.2 out of 5, with 84% one-star reviews, per third-party snapshots. And on September 9, 2025, the FDA sent Sprout Health a warning letter for calling its compounded GLP-1s FDA-approved. They are not. The site has since fixed the claim — and we will give both halves of that story their due.
Our score: 6.4 out of 10 — Fair. Here is the math behind it, dollar by dollar.
Sprout Health in 60 Seconds
Sprout Health is a cash-pay telehealth clinic run by Sprout Health Partners LLC out of Encinitas, California. A licensed clinician reviews your health history online, then partner pharmacies ship compounded semaglutide from $149/mo or compounded tirzepatide from $199/mo. Brand-name Wegovy ($1,799/mo) and Zepbound ($1,999/mo) are on the menu too. No insurance is accepted, and none is needed — one flat cash price.
Two features genuinely stand out. First, the written price-lock: the site pledges that your agreed monthly payment will never increase, even when your dosage climbs in later months. Second, a sublingual semaglutide option — drops under the tongue instead of a weekly needle. Few rivals offer any non-injectable form; MEDVi (7.6/10) is the other name on our board with one.
The catch is track record — or the lack of one. Per its BBB profile, the business started January 29, 2025. That makes it roughly 18 months old as of this July 2026 update. In that short life it has collected an F rating, a 2.2-ish Trustpilot score, and a federal warning letter. That is a lot of damage, fast.
The Sprout Health Review Scorecard
| Metric | The number |
|---|---|
| Our rating | 6.4/10 — Fair |
| Advertised starting price | $149/mo (compounded semaglutide) |
| Price-lock | Yes — in writing, even if your dose increases |
| BBB rating | F, 63 complaints, 32 unanswered |
| Trustpilot | ~2.2/5, 84% one-star (per third-party snapshots) |
| FDA warning letter | Yes — Sept 9, 2025; claim since corrected |
| States excluded | Arkansas, Kansas, New Mexico (compounded meds) |
| Delivery | 5-7 business days after prescription |
One baseline before the money talk. The underlying drugs perform in trials: semaglutide 2.4 mg produced an average 14.9% body-weight loss over 68 weeks in the STEP 1 trial, and tirzepatide delivered up to 20.9% average loss over 72 weeks in SURMOUNT-1. Those results come from the FDA-approved brand products. Compounded versions are not FDA-approved, and Sprout Health’s own site now states the FDA has not evaluated them for safety, effectiveness, or quality.
Sprout Health Cost Breakdown (2026)
Sticker prices first, as displayed on joinsprouthealth.com in July 2026.
| Product | Advertised price | The fine print |
|---|---|---|
| Compounded semaglutide (injection or sublingual) | from $149/mo | Not FDA-approved; homepage figure |
| Semaglutide 3-month supply | $465 promo (~$155/mo), regular $615 | Promo prices shift over time |
| Compounded tirzepatide | from $199/mo, regular $349 | Not FDA-approved |
| Brand-name Wegovy | from $1,799/mo | FDA-approved; cash pay only |
| Brand-name Zepbound | from $1,999/mo | FDA-approved; cash pay only |
| Compounded NAD+ | from $199/mo | Separate wellness add-on |
Now the yearly math. At $149/mo, compounded semaglutide runs $1,788 a year. Buy the 3-month promo four times and you pay $1,860. Let the promo lapse to the $615 regular rate and the year jumps to $2,460 — about $205 a month. That spread is why we tell readers to price the whole market first in our semaglutide cost guide before committing anywhere.
The price-lock is the real differentiator. Sprout Health commits, on its own product pages, that the agreed monthly payment never rises — even when your dosage increases — and that the fee bundles clinician review, medication, shipping, ongoing oversight, and auto-refills. It also states there are no hidden fees and no separate membership or consultation charges. Most GLP-1 clinics raise prices as doses escalate, so on paper this is a $0-escalation guarantee in a market full of stealth increases.
Two caveats keep us skeptical. First, displayed prices move. Per third-party pricing reports, older figures ran $199 for the first month and then $249/mo, or $249 to $299/mo flat — so today’s $149 looks promotional. The get-started page even ran a $250-off first month countdown timer. Screenshot your checkout price. Second, the refund policy is narrow: you get your money back only if the clinician rules you ineligible. Once medication ships, no returns, no refunds — and the subscription auto-refills until you cancel.
What Customers Complain About — and What They Praise
The review file is grim for a company this young. Trustpilot for joinsprouthealth.com is reported at 2.2 out of 5 across 113 reviews, with 84% one-star, per third-party snapshots. Two themes dominate: support that cannot be reached and subscriptions that are hard to cancel.
The BBB file is worse. The F rating exists because Sprout Health failed to answer 32 of its 63 complaints. The complaint details matter: customers allege being charged within minutes of applying, before any consultation happened; packages arriving with medication missing; and nobody picking up when they tried to cancel. These are customer allegations, not court findings. But they rhyme with the Trustpilot record, and an auto-refill business that will not answer its cancel line is a specific, expensive kind of problem.
What do customers praise? Honestly, the documented praise is thin, and we will not pad it. The features pulling people in are real on paper: a $149 entry price, the written price-lock, the no-needle sublingual option, 5-7 day delivery, and a refund if you are ruled ineligible. For context, this complaint profile sits near the bottom of our 11-provider board — only altRx (6/10) scores lower, with its own F rating and FDA letter.
The FDA Letter Every Sprout Health Review Must Explain
On September 9, 2025, FDA’s Center for Drug Evaluation and Research issued warning letter #715879 to Sprout Health Partners LLC dba Sprout Health, following an August 2025 review of its website. The agency cited the site’s statement that “GLP-1 medications are FDA-approved and backed by extensive clinical research” — made about compounded semaglutide and tirzepatide, which are not FDA-approved. The FDA called that misbranding under sections 502(a) and 502(bb) of the FD&C Act and gave the company 15 working days to respond.
Both halves of this story deserve print. The bad half: the federal drug regulator told this company, in writing, that it falsely advertised approval on the exact products it sells — inside its first year of business. The better half: the claim has been corrected. As of July 2026, the site plainly discloses that its compounded GLP-1s are not approved by the FDA and have not been evaluated for safety, effectiveness, or quality. That fix is real and we credit it.
But context stays. The FDA has published broader concerns about unapproved GLP-1 drugs — dosing errors, unverified ingredients, products the agency never reviewed. Against that backdrop, Sprout Health says its medications are compounded in the USA by licensed pharmacies, yet never names those pharmacies or says whether they are 503A or 503B facilities. After a misbranding letter, that silence costs points — roughly 100% of the transparency we want, 0% delivered.
How Ordering From Sprout Health Works
The funnel is a six-step, fully online process. Here it is, with the checkpoints we would watch.
Steps 1-2: Quiz, then checkout. You take a quick pre-qualification quiz and purchase the plan up front — $149 to $199/mo for compounded options. Note the order: payment comes before the medical review. BBB complaints allege charges landing within minutes of applying, so understand that your card is in the game early.
Steps 3-4: Questionnaire and clinician review. You complete a detailed medical questionnaire, and a licensed clinician reviews your health history. If you are ruled ineligible, the order is cancelled and refunded — a genuinely fair term. But there is no required lab work and no mandatory live video visit; the process can be 100% asynchronous. Third-party reviewers flag that as thinner screening than the best clinics run.
Steps 5-6: Pharmacy and delivery. Approved prescriptions reach the partner pharmacy within 2 business days, and the whole prescribed-to-doorstep run typically takes 5-7 business days. Compounded medications cannot ship to Arkansas, Kansas, or New Mexico. The subscription auto-refills until you pause or cancel, cancellation must happen before the next shipment, and shipped medication is non-returnable.
If you proceed, protect yourself like the complaint file is accurate: screenshot the checkout price, calendar the refill date a week early, keep records of every cancellation attempt to (833) 496-4020 and [email protected], and pay with a card that makes disputes easy.
Sprout Health vs Noom Med
Our top alternative is Noom Med (8.7/10 — Very Good). Same drug category, very different company.
| Sprout Health | Noom Med | |
|---|---|---|
| Our score | 6.4/10 — Fair | 8.7/10 — Very Good |
| Compounded semaglutide | from $149/mo | $129 first month, then $249/mo billed quarterly |
| Company operating since | January 2025 | 2008 (Noom Med since 2023) |
| BBB record | F, 32 unanswered complaints | A+, accredited since 2021 |
| FDA warning letter | Yes — Sept 2025 (claim since corrected) | None documented |
| Pharmacy transparency | Partners never named | FDA-regulated 503B facility, per Noom’s press release |
| No-needle option | Sublingual semaglutide | None (oral plan is metformin, a different drug) |
| States excluded (compounded) | AR, KS, NM | AL, LA, MS |
Sprout Health wins the price column. At $149/mo versus Noom’s $249/mo recurring rate, the gap is about $100 a month — $1,200 a year. It also wins for needle-phobes, since Noom Med has no sublingual semaglutide.
Noom Med wins everything else. An A+ BBB record versus an F. Eighteen years of corporate history versus eighteen months. A named, FDA-regulated 503B production source versus anonymous pharmacies. No federal warning letters. Plus a Taper-Off Guarantee tied to its behavior program. To us, $100 a month is the going rate for a company that answers its complaints — and you can see how both stack against nine rivals in our best semaglutide programs ranking.
Final Verdict: Who Should Actually Buy
Sprout Health: 6.4/10 — Fair. Second-lowest score on our board, ahead of only altRx at 6/10.
There is a narrow honest buyer here: someone who cannot or will not inject, wants compounded semaglutide near $149/mo, and values a written price-lock enough to accept the customer-service risk documented above. Even then, compare first — MEDVi (7.6/10) sells dissolvable semaglutide tablets from $249 for month one with a 4.4/5 Trustpilot score across roughly 14,000 reviews, though it carries a BBB F file of its own.
Everyone else should pay up for Noom Med at $129 for month one. The extra $100 a month buys an A+ complaint record, a named 503B source, and a company old enough to have a reputation worth protecting.
The scoreboard on Sprout Health is short and sharp. One FDA warning letter — corrected, but earned. One BBB F rating. 32 ignored complaints. 84% one-star reviews. Against that: a $149 price, a real price-lock, and no needles. That trade is Fair. It is not better than Fair.